Modulation and intracellular transport of CD20 and CD21 antigens induced by B1 and B2 monoclonal antibodies in RAJI and JOK-1 cells--an immunofluorescence and immunoelectron microscopy study

Leukemia Research
S PulczynskiO M Jensen

Abstract

By fluorescence microscopy (FM), flow cytometry (FCM) and immunoelectron microscopy (IEM) we have shown that B1 and B2 monoclonal antibodies (MoAbs) were able to induce modulation of CD20 and CD21 in RAJI and JOK-1 cell lines. Redistribution and internalization of both antigens (Ags) after binding with MoAbs was readily demonstrated by FM, and by IEM CD20 and CD21 were found to be processed by the pathway of receptor-mediated endocytosis. The rate of intracellular transport varied: CD21 > CD20 and RAJI > JOK-1. Approximately 65 and 55% of CD20 and 60 and 45% of CD21 were cleared from the surface of RAJI and JOK-1 cells, respectively (FCM and IEM). These values, however, clearly exceeded those corresponding to internalization (11, 9, 24 and 16%) indicating shedding of Ag-MoAb complexes. No evidence of recycling was found. The present data support the hypothesis that the kinetics of modulation vary from one Ag to another and probably also reflect the stage of differentiation of the malignant B-cells. The results are discussed in the context of the possible usefulness of B1 and B2 MoAbs in the therapy of B-cell malignancies.

References

Jun 1, 1992·Journal of Virology·N Miller, L M Hutt-Fletcher
Jan 1, 1991·Leukemia Research·A EngertP Thorpe
Jan 1, 1991·Biotherapy·O W Press
Mar 15, 1990·International Journal of Cancer. Journal International Du Cancer·M CironeA Faggioni
May 1, 1990·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·D A ScheinbergL J Old
Jul 1, 1989·Proceedings of the National Academy of Sciences of the United States of America·U C Wargalla, R A Reisfeld
Oct 1, 1989·Annals of Internal Medicine·R O Dillman
Nov 15, 1985·The Biochemical Journal·T WilemanP Stahl
Nov 1, 1988·British Journal of Haematology·F W PreijersP J Capel
Mar 1, 1988·Journal of Clinical Immunology·N K Ramsay, J H Kersey
Nov 20, 1987·Science·E S VitettaJ W Uhr
Jul 1, 1984·Proceedings of the National Academy of Sciences of the United States of America·J D FingerothD T Fearon
Jan 1, 1981·Annual Review of Physiology·I H Pastan, M C Willingham
Dec 11, 1980·The New England Journal of Medicine·P H Black

❮ Previous
Next ❯

Citations

Mar 6, 2002·Annals of Anatomy = Anatomischer Anzeiger : Official Organ of the Anatomische Gesellschaft·Olaf Burkhardt, Hans-Joachim Merker
Mar 6, 2002·Annals of Anatomy = Anatomischer Anzeiger : Official Organ of the Anatomische Gesellschaft·Olaf Burkhardt, Hans-Joachim Merker
Jun 1, 2007·Molecular Oncology·Tsipi Ben-KasusYosef Yarden
Sep 9, 2010·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Jun AmanoMasaki Ishigai
Dec 9, 2004·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Che-Leung LawAlan F Wahl

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antigenic Modulation

Antigenic modulation occurs when an antibody cross-links antigens on a cell surface, causing the antigens to become internalized. This can lead to therapeutic failure of monoclonal antibodies as the expression of the antigen becomes decreased on target cells. Find the latest research on antigenic modulation here.

B-Cell Leukemia (Keystone)

B-cell leukemia includes various types of lymphoid leukemia that affect B cells. Here is the latest research on B-cell leukemia.